Wegovy

News

FDA lends a hand to Novo, Lilly on illegal GLP-1 imports

The FDA has set up a green list of overseas sources for GLP-1 ingredients to try to block imports of illegitimate and potentially unsafe materials.

News

ESC: Real-world study gives Wegovy edge over Lilly rival

Novo Nordisk has latched onto a real-world study that found its weight-loss drug Wegovy works better than Eli Lilly's fast-growing rival Zepbound.

News

Novo Nordisk cuts GLP-1 prices for cash buyers

Novo Nordisk has said it will offer diabetes therapy Ozempic at $499 per month for cash-paying customers in the US.

News

Novo Nordisk claims first GLP-1 approval in MASH

Under pressure from rivals in the GLP-1 space, Novo Nordisk has been given a leg-up with a first-in-class approval for Wegovy in liver disease MASH.

News

Novo Nordisk weakens again on interim results readout

Novo Nordisk's already depressed share price has fallen again this morning, despite reporting an 18% increase in sales in the first half of this year.

News

Noom Med app and accompanying GLP-1 implements

Noom expands its GLP-1 range with 'microdose' package

Noom is offering 'microdoses' of semaglutide at a knock-down price, claiming they can prevent side effects but remain effective for weight loss.

FDA lends a hand to Novo, Lilly on illegal GLP-1 imports

ESC: Real-world study gives Wegovy edge over Lilly rival

Novo Nordisk cuts GLP-1 prices for cash buyers

Novo Nordisk claims first GLP-1 approval in MASH

Novo Nordisk weakens again on interim results readout

Noom expands its GLP-1 range with 'microdose' package

NHS staff 'feel unprepared for digital transformation'

How to meet your physicians where they are online

Wegovy

Editor's Picks